Roberts David B 4
4 · LEMAITRE VASCULAR INC · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Lemaitre Vascular (LMAT) President David Roberts Exercises Options
What Happened
- David B. Roberts, President and Director of Lemaitre Vascular (LMAT), exercised vested stock options on 2026-02-05. He acquired 2,672 shares at an exercise price of $37.29 (cost $99,639) and 7 shares at $48.60 (cost $340), for a total of 2,679 shares and total cash paid of $99,979. The filing records the original derivative option interests as disposed (cancelled) in connection with the exercises (reported at $0.00).
Key Details
- Transaction date: 2026-02-05 (reported on Form 4 filed 2026-02-06)
- Prices and quantities: 2,672 shares @ $37.29 ( $99,639 ); 7 shares @ $48.60 ( $340 ); combined 2,679 shares, $99,979 paid
- SEC transaction code: M = Option exercise/conversion
- Shares owned after transaction: Not specified in the Form 4 provided
- Footnotes: F1 — shares reported as acquired upon exercise; F2 — the option was fully vested and exercisable
- Filing timeliness: Reported the next day (appears timely; no late filing indicated)
Context
- These were option exercises (not open-market sales); the filing does not show any immediate sale of the acquired shares (i.e., not a cashless exercise reported). Exercising vested options converts the option (a derivative) into common shares and cancels the option interest.
Insider Transaction Report
Form 4
Roberts David B
DirectorPresident and Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-05$37.29/sh+2,672$99,639→ 24,923 total - Exercise/Conversion
Common Stock
[F1]2026-02-05$48.60/sh+7$340→ 24,930 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-02-05−2,672→ 0 totalExercise: $37.29From: 2020-12-02Exp: 2027-12-02→ Common Stock (2,672 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2026-02-05−7→ 14,054 totalExercise: $48.60From: 2021-12-11Exp: 2028-12-11→ Common Stock (7 underlying)
Footnotes (2)
- [F1]Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- [F2]This option is fully vested and exercisable.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-02-06